Press Room

Prostate cancer survivors, physicians and cancer advocates gathered at the Pennsylvania State Capitol to urge swift passage of legislation that would expand access to prostate cancer screening for high-risk men. The proposals--House Bill 281 and Senate Bill 447—would remove cost-sharing requirements for those at high-risk of developing prostate cancer that currently keep too many Pennsylvanians from getting screened.

Austin, TX. – With the end of the 2025 Texas legislative session, the American Cancer Society Cancer Action Network (ACS CAN) is optimistic that more people will have access to cancer prevention and early detection services and reinforces its commitment to this effort.   

Pennsylvania lawmakers have taken a critical step in efforts to prevent cancer and reduce its burden on Pennsylvanians by introducing HB 281 and SB 447. If passed, the legislation would eliminate out-of-pocket costs for lifesaving prostate cancer screenings for men at high-risk of developing prostate cancer, thus reducing barriers and increasing access to care for men over 40 with certain high-risk factors.

According to multiple news reports, Former President Joe Biden has been diagnosed with an “aggressive” form of prostate cancer that has spread to his bones.

Over 120 volunteer advocates from across Pennsylvania, including cancer survivors, patients and caregivers, convened at the state Capitol yesterday for ‘Cancer Action Day,’ an event hosted annually by the American Cancer Society Cancer Action Network (ACS CAN). Advocates met with their state lawmakers and urged them to support policies that aid in the fight against cancer. 

Volunteer advocates, including cancer survivors, patients,

Advocates with the American Cancer Society Cancer Action Network (ACS CAN) join Arizonans in mourning the loss of Rep. Raúl Grijalva, who died Thursday after complications from battling lung cancer. 

During his more than two decades of serving in Congress, Rep. Grijalva championed efforts to improve public health by advocating for the development of new health care clinics in Southern Arizona, as well as supporting efforts to increase access to care by co-sponsoring bipartisan legislation to aid in the fight against cancer. 

Today, the U.S. House passed The Full-Year Continuing Appropriations and Extensions Act, 2025. It contains no increases for federal cancer research or prevention funding and significant cuts to Congressionally Directed Medical Research Programs (CDMRP), in which cancer is the largest recipient of funds. 

Today, the Prostate-Specific Antigen Screening for High-risk Insured Men (PSA Screening for HIM) Act was introduced in the United States House of Representatives by Representatives Neal Dunn, M.D. (R-FL) and Yvette Clarke (D-NY) with Representatives Greg Murphy (R-NC) and Troy Carter (D-LA) as cosponsors.

Bipartisan legislation that would remove financial barriers to prostate cancer screening was introduced today in the U.S. Senate. Sponsored by Senators John Boozman (R-AR) and Cory Booker (D-NJ), the Prostate-Specific Antigen Screening for High-risk Insured Men (PSA Screening for HIM) Act would waive cost-sharing requirements such as deductibles, copayments and coinsurance, for prostate cancer screening tests for men with the highest risk of prostate cancer, including Black men and those with a family history of the disease.